Postnatal Magnesium Trend in less than 34 week Preterms who received Antenatal Neuroprotective Doses of Magnesium Sulphate
DOI:
https://doi.org/10.52314/fnb.2021.v1i2.17Keywords:
Magnesium Sulphate, Neuroprotection, Magnesium LevelAbstract
Antenatal magnesium sulphate is one of the neuro protective strategies used for preterm deliveries. One of the concerns with this is whether it leads to hypermagnesemia in newborns. Postnatal magnesium levels were studied in 70 preterms whose mothers received magnesium sulphate. No baby had hypermagnesemia. The mean cord blood magnesium level was 2.76 mg/dl which came down to 2.37 mg/dl by 24 hours of life. Babies who needed labour room resuscitation had slightly elevated cord blood magnesium.
Downloads
Published
2021-10-14
How to Cite
1.
Sarath MB, Anand MR, Remesh P, Nath D, Mohan V. Postnatal Magnesium Trend in less than 34 week Preterms who received Antenatal Neuroprotective Doses of Magnesium Sulphate. FNB [Internet]. 2021 Oct. 14 [cited 2022 May 27];1(2):34-7. Available from: https://www.fetusandnewborn.com/journal/index.php/fnb/article/view/17
Issue
Section
Original Research
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.